Abstract:A20 was originally characterized as a TNF-inducible gene in human umbilical vein endothelial cells. As an NF-kappa B target gene, A20 is also induced in many other cell types by a wide range of stimuli. Expression of A20 has been shown to protect from TNF-induced apoptosis and also functions via a negative-feedback loop to block NF-kappa B activation induced by TNF and other stimuli. To date, there are no reports on whether A20 can protect OxLDL-induced apoptosis in macrophages. For the first time we report that A20 expression blocks OxLDL-mediated cell toxicity and apoptosis. OxLDL induced the expression of Fas and FasL, and the subsequent caspase-8 cleavage and treatment with a neutralizing ZB4 anti-Fas antibody blocked apoptosis induced by OxLDL. Expression of dominant negative FADD efficiently prevented OxLDL-induced apoptosis and caspase-8 activation. A20 expression significantly attenuated the increased expression of Fas and FasL, and Fas-mediated apoptosis. These findings suggest that A20-mediated protection from OxLDL may occur at the level of Fas/FADD-caspase-8 and be FasL dependent. Treatment of RAW264.7 cells with OxLDL induces a series of time-dependent events, including the release of cytochrome c, Smac and Omi from the mitochondria to the cytosol, activation of caspase-9,-6,-2, and -3, which are blocked by A20 expression. No cleaved form of Bid was detected, even treatment with OxLDL for 48 h. Expression of dominant negative FADD also efficiently prevented OxLDL-induced the above apoptotic events. The release of cyto c, Smac and Omi from mitochondria to cytosol, activated by OxLDL treatment, and the activation of caspase-9 may not be a downstream event of caspase-8-mediated Bid cleavage. Therefore, the protective effect of A20 on mitochondrial apoptotic pathway activated by OxLDL may be dependent on FADD. A20 expression reversed OxLDL-mediated G(0)/G(1) stage arrest by maintaining the expression of cyclin B1, cyclin D1, and cyclin E, and p21 and p73. Thus, A20 expression blocks OxLDL-mediated apoptosis in murine RAW264.7 macrophages through disrupting Fas/FasL-dependent activation of caspase-8 and the mitochondria pathway.

A20 Inhibits Oxidized Low‐density Lipoprotein‐induced Apoptosis Through Negative Fas/Fas Ligand‐dependent Activation of Caspase‐8 and Mitochondrial Pathways in Murine RAW264.7 Macrophages

A20 Overexpression under Control of Mouse Osteocalcin Promoter in MC3T3-E1 Cells Inhibited Tumor Necrosis Factor-Alpha-induced Apoptosis.

Neuroprotective Effect of A20 on TNF-Induced Postischemic Apoptosis

Antiapoptotic Effect Both in Vivo and in Vitro of A20 Gene when Transfected into Rat Hippocampal Neurons

A20 Attenuates Ffas-Induced Lipid Accumulation In Nonalcoholic Steatohepatitis

A20 prevents obesity-induced development of cardiac dysfunction

G protein-coupled receptor 39 activation alleviates oxidized low-density lipoprotein-induced macrophage inflammatory response, lipid accumulation and apoptosis by inducing A20 expression

A20 Rescues Hepatocytes from Apoptosis Through the NF-κB Signaling Pathway in Rats with Acute Liver Failure.

Targeting A20 Enhances TRAIL-induced Apoptosis in Hepatocellular Carcinoma Cells

A20 functions as a negative regulator in macrophage for DSS-induced colitis

A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo

Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation

Effects of Zinc Finger Protein A20 on Lipopolysaccharide (Lps)-Induced Pulmonary Inflammation/Anti-Inflammatory Mediators in an Acute Lung Injury/Acute Respiratory Distress Syndrome Rat Model.

A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling

A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses

Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction

Tumor Suppressor A20 Protects Against Cardiac Hypertrophy and Fibrosis by Blocking Transforming Growth Factor- -Activated Kinase 1-Dependent Signaling

Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling

Inhibition of A20 Expression in Tumor Microenvironment Exerts Anti-Tumor Effect Through Inducing Myeloid-Derived Suppressor Cells Apoptosis

A20 Protein Regulates Lipopolysaccharide-Induced Acute Lung Injury by Downregulation of NF-κB and Macrophage Polarization in Rats.

miR-155 inhibits oxidized low-density lipoprotein-induced apoptosis of RAW264.7 cells